Boston Scientific agrees takeover of Securus Medical Group

Boston Scientific has announced the acquisition of Securus Medical Group in a deal worth up to $50 million (GBP 35.32 million).

The firm has been an investor in Securus since 2016, and is now purchasing the remaining stake it does not already own for $40 million in cash upfront, as well as $10 million in contingent payments based on regulatory achievements and commercial milestones.

Securus has developed a thermal monitoring system for the continuous measurement of oesophageal temperature, consisting of an integrated catheter-based probe and imaging system that generates real-time images of the temperature of the oesophagus.

Arrhythmias are commonly treated with cardiac ablation, a process that uses variable temperatures to destroy areas of heart muscle responsible for the abnormal heart rhythm. Physicians rely on temperature monitoring during the ablation procedure to avoid thermal injury.

Joe Fitzgerald, president of rhythm management at Boston Scientific, said: "The acquisition of Securus further broadens our electrophysiology portfolio and fuels our mission to provide physicians with meaningful innovations that advance patient care."

With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.